中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2026-09-302026-06-302026-03-312025-12-312025-09-30
营业总收入(万元)32278.8021130.379250.2237834.3627155.36
营业收入(万元)32278.8021130.379250.2237834.3627155.36
营业总成本(万元)36654.7023926.1310790.5046308.1131578.33
营业成本(万元)26138.5317019.466997.5127854.7019182.20
净利润(万元)-4095.58-2796.08-1050.97-6834.34-3016.11
归属于母公司的净利润(万元)-4095.58-2796.08-1050.97-6966.10-3016.11
营业利润(万元)-4339.76-2867.30-1342.74-7175.75-3635.82
利润总额(万元)-4340.21-2867.93-1345.97-7238.54-3650.96
少数股东损益(万元)----------
基本每股收益(元)-0.32(元)-0.22(元)-0.08(元)-0.55(元)-0.24(元)
稀释每股收益(元)-0.32(元)-0.22(元)-0.08(元)-0.55(元)-0.24(元)
非经常性损益(万元)----148.88--578.18
扣除非经常性损益后净利润(万元)-4493.49-3067.64-1199.85-7893.81-3594.28
总资产(万元)161545.30163231.23165097.04166529.64168936.52
总负债(万元)17040.6017398.8217607.2218111.9716700.62
归属于母公司股东权益合计(万元)144504.70145832.41147489.82148417.67152235.90
股东权益合计(万元)144504.70145832.41147489.82148417.67152235.90
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)62681.6363981.1365726.2466777.2170727.20
经营活动产生的现金流量净额(万元)-601.80-455.15-140.95-2618.69-2278.96
经营活动现金流入小计(万元)25654.6217215.458368.0231023.8124574.20
经营活动现金流出小计(万元)26256.4217670.618508.9733642.5026853.16
投资活动产生的现金流量净额(万元)-2375.56-3249.60846.957054.062434.03
投资活动现金流入小计(万元)42177.2021109.517534.7498499.5572891.16
投资活动现金流出小计(万元)44552.7624359.116687.7991445.4970457.13
筹资活动产生的现金流量净额(万元)-113.249.185.18-121.00-122.42
筹资活动现金流入小计(万元)9.189.185.181.42--
筹资活动现金流出小计(万元)122.42----122.42122.42
期末现金及现金等价物余额(万元)7286.496716.0611145.9110463.756195.39
最后修改日期2026-10-262026-08-272026-04-282026-03-282025-10-29
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。